866-997-4948(US-Canada Toll Free)

Biosensors International Group, Ltd. (B20) - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Oct 2012

Category :

Competitive Analysis

No. of Pages : 55 Pages


Biosensors International Group, Ltd. (Biosensors) is a medical devices company. It undertakes the development, manufacturing and marketing of medical devices utilized in interventional cardiology and critical care procedures. The company develops drug-eluting stents (DES) and a pipeline of next-generation products set to gain market share from traditional therapies such as conventional drug eluting stents, bare-metal stent and balloon dilatation catheters. It is also focused on the technology addressing a DES system, including the stent, delivery catheter, polymer and proprietary drug. The company operates in Singapore, Switzerland, China, US, Japan, Indonesia, India, France, Germany and Netherlands. Biosensors is headquartered in Singapore.

This report is a source for data, analysis and actionable intelligence on the Biosensors International Group, Ltd. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.
  • Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 4

Biosensors International Group, Ltd. - Business Description 5

Key Facts 6
Biosensors International Group, Ltd. - Major Products and Services 7
Biosensors International Group, Ltd. Pipeline Products by Equipment Type 8
Biosensors International Group, Ltd. Pipeline Products by Development Stage 9
Biosensors International Group, Ltd. Pipeline Products by Therapy Area 11
Biosensors International Group, Ltd. Pipeline Products by Trial Phase 14
Biosensors International Group, Ltd. Pipeline Products by Milestone Summary 16
BioFreedom Drug Coated Stent 18
BioFreedom Drug Coated Stent Product Status 18
BioFreedom Drug Coated Stent Product Description 18
BioFreedom Drug Coated Stent Product Milestone 18
BioFreedom Drug Coated Stent Clinical Trial 19
BioFreedom Drug Coated Stent Product Patent Details 26
BioMatrix Drug Eluting Stent 27
BioMatrix Drug Eluting Stent Product Status 27
BioMatrix Drug Eluting Stent Product Description 27
BioMatrix Drug Eluting Stent Product Milestone 27
BioMatrix Drug Eluting Stent Clinical Trial 28
BioMatrix Drug Eluting Stent Product Patent Details 38
Sparrow Drug Eluting Stent System 39
Sparrow Drug Eluting Stent System Product Status 39
Sparrow Drug Eluting Stent System Product Description 39
Sparrow Drug Eluting Stent System Product Milestone 39
Sparrow Drug Eluting Stent System Clinical Trial 40
Biosensors International Group, Ltd. - Key Competitors 42
Biosensors International Group, Ltd. - Key Employees 43
Biosensors International Group, Ltd. - Key Employee Biographies 44
Biosensors International Group, Ltd. - Locations And Subsidiaries 45
Head Office 45
Other Locations & Subsidiaries 45
Recent Developments 47
Biosensors International Group, Ltd., Recent Developments 47
May 29, 2012: Biosensors Reports Revenue Of $292.1m In Fiscal 2012 47
May 09, 2012: Biosensors Announces Incorporation Of New Subsidiary 48
Mar 09, 2012: Biosensors Announces Senior Management Changes 48
Mar 09, 2012: Biosensors To Develop New Manufacturing, R&D Innovation Center And Operations Headquarter In Singapore 49
Feb 08, 2012: Biosensors Reports Revenue Of $84.8m In Q3 Fiscal 2012 49
Jan 06, 2012: Biosensors Appoints Eizo Nishimura As Its President Of Biosensors Japan 50
Nov 02, 2011: Biosensors Reports Revenues Of $62.2m In Q2 Fiscal 2012 51
Jul 27, 2011: Biosensors Reports Total Revenue Of $57m In Q1 Fiscal Year Ended 2012 51
May 26, 2011: Drug-Eluting Stents Using Biodegradable Polymer Significantly Improve Overall Clinical Outcomes 52
May 26, 2011: Biosensors Reports Total Revenue Of $156.6m In Fiscal Year Ended 2011 53

Appendix 55
Methodology 55
About GlobalData 55
Contact Us 55
Disclaimer 55

List of Table


Biosensors International Group, Ltd., Key Facts 1
Biosensors International Group, Ltd. Key Pipeline Products by Equipment Type 1
Biosensors International Group, Ltd. Key Pipeline Products by Therapy Area 1
Biosensors International Group, Ltd. Key Pipeline Products by Development Stage 1
Biosensors International Group, Ltd. Key Pipeline Products by Trial Phase 1
Biosensors International Group, Ltd., Key Facts 6
Biosensors International Group, Ltd., Major Products and Services 7
Biosensors International Group, Ltd. Number of Pipeline Products by Equipment Type 8
Biosensors International Group, Ltd. Pipeline Products by Equipment Type 8
Biosensors International Group, Ltd. Number of Pipeline Products by Development Stage 9
Biosensors International Group, Ltd. Pipeline Products by Development Stage 10
Biosensors International Group, Ltd. Number of Pipeline Products by Therapy Area 11
Biosensors International Group, Ltd. Pipeline Products by Therapy Area 12
Biosensors International Group, Ltd. Number of Pipeline Products by Trial Phase 14
Biosensors International Group, Ltd. Pipeline Products by Trial Phase 15
Biosensors International Group, Ltd. Number of Pipeline Products By Milestone Summary 16
Biosensors International Group, Ltd. Pipeline Products by Milestone Summary 17
BioFreedom Drug Coated Stent - Product Status 18
BioFreedom Drug Coated Stent - Product Description 18
BioFreedom Drug Coated Stent - Product Milestone 18
BioFreedom Drug Coated Stent - A Prospective, Multi-Centre First-In-Man Study To Assess The Safety And Efficacy Of BioFreedom 19
BioFreedom Drug Coated Stent - A Prospective, Single Blinded, Randomized Study to Evaluate the Safety and Effictiveness of a Low and Standard Dose Biolimus A9 Drug-Eluteing Coronary Stent Delivery System Compared With a Taxus Liberte Control Arm for Treatment of Stenotic Lesions in Native Coronary Arteries 20
BioFreedom Drug Coated Stent - A Prospective, Randomized Double-Blind Trial Between a drug-coated stent (DCS) and Bare-Metal Stent (BMS) 24
BioFreedom Drug Coated Stent - A Prospective Randomized Comparison of the BioFreedom Biolimus A9 Drug Coated Stent Versus the Gazelle Bare Metal Stent in Patients With High Risk of Bleeding 25
BioFreedom Drug Coated Stent - Patent Details1 26
BioFreedom Drug Coated Stent - Patent Details2 26
BioMatrix Drug Eluting Stent - Product Status 27
BioMatrix Drug Eluting Stent - Product Description 27
BioMatrix Drug Eluting Stent - Product Milestone 27
BioMatrix Drug Eluting Stent - STentEluting A9 BioLimusTrial In Humans 28
BioMatrix Drug Eluting Stent - Assessment of Vessel Healing After DES Implantation With STEMI, NSTEMI and Stable/Unstable Angina Patients: a Randomized Study Between Everolimus and Biolimus A9-eluting Stents: an Optical Coherence Tomography (OCT) and Intravascular Ultrasound Tissue Characterisation (IVUS-TC) Study 30
BioMatrix Drug Eluting Stent - Randomized Comparison of Outcome of Stenting in Unselected Patients in Everyday Clinical Practice 32
BioMatrix Drug Eluting Stent - Comparison of Biolimus Eluted From an Erodable Stent Coating With Bare-Metal Stents in Acute ST-Elevation Myocardial Infarction and In Vivo 3-Vessel Assessment of Time-Related Changes of Culprit and Non-Culprit Lesions by IVUS/OCT in AMI 34
BioMatrix Drug Eluting Stent - Prospective Optical cohereNce Tomography Evaluation of neoINtimal Coverage of a biodegrAdable Polymer-based Drug-eluting Stent 36
BioMatrix Drug Eluting Stent - Patent Details1 38
Sparrow Drug Eluting Stent System - Product Status 39
Sparrow Drug Eluting Stent System - Product Description 39
Sparrow Drug Eluting Stent System - Product Milestone 39
Sparrow Drug Eluting Stent System - CARE II Clinical Trial 40
Biosensors International Group, Ltd., Key Employees 43
Biosensors International Group, Ltd., Key Employee Biographies 44
Biosensors International Group, Ltd., Other Locations 45
Biosensors International Group, Ltd., Subsidiaries 45

List of Chart


Biosensors International Group, Ltd. Pipeline Products by Equipment Type 8
Biosensors International Group, Ltd. Pipeline Products by Development Stage 9
Biosensors International Group, Ltd. Pipeline Products by Therapy Area 11
Biosensors International Group, Ltd. Pipeline Products by Trial Phase 14
Biosensors International Group, Ltd. Pipeline Products by Milestone Summary 16

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *